67 related articles for article (PubMed ID: 21238623)
21. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of manganese superoxide dismutase and catalase in lung cancer.
Chung-man Ho J; Zheng S; Comhair SA; Farver C; Erzurum SC
Cancer Res; 2001 Dec; 61(23):8578-85. PubMed ID: 11731445
[TBL] [Abstract][Full Text] [Related]
23. Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism.
Cetinkaya A; Kurutas EB; Buyukbese MA; Kantarceken B; Bulbuloglu E
Mediators Inflamm; 2005 Feb; 2005(1):57-9. PubMed ID: 15770068
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
[TBL] [Abstract][Full Text] [Related]
26. Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients.
Cheng YK; Hwang GY; Lin CD; Tsai MH; Tsai SW; Chang WC
Laryngoscope; 2006 Mar; 116(3):417-22. PubMed ID: 16540901
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C eta is associated with progression of renal cell carcinoma (RCC).
Brenner W; Färber G; Herget T; Wiesner C; Hengstler JG; Thüroff JW
Anticancer Res; 2003; 23(5A):4001-6. PubMed ID: 14666709
[TBL] [Abstract][Full Text] [Related]
28. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages.
Kasapović J; Pejić S; Todorović A; Stojiljković V; Pajović SB
Cell Biochem Funct; 2008 Aug; 26(6):723-30. PubMed ID: 18636415
[TBL] [Abstract][Full Text] [Related]
30. Expression of beta-catenin in renal cell carcinoma.
Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
[TBL] [Abstract][Full Text] [Related]
31. Immunogold analysis of antioxidant enzymes in human renal cell carcinoma.
Oberley TD; Sempf JM; Oberley MJ; McCormick ML; Muse KE; Oberley LW
Virchows Arch; 1994; 424(2):155-64. PubMed ID: 8180777
[TBL] [Abstract][Full Text] [Related]
32. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
33. Significance of COX-2 expression in human renal cell carcinoma.
Tuna B; Yorukoglu K; Gurel D; Mungan U; Kirkali Z
Urology; 2004 Dec; 64(6):1116-20. PubMed ID: 15596182
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
35. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Kawauchi A; Nakao M; Miki T
Cancer; 2003 Aug; 98(4):730-6. PubMed ID: 12910516
[TBL] [Abstract][Full Text] [Related]
36. Detection, staging and clinical implications of renal cell carcinoma.
Ghalayini IF; Bani-Hani IH
Saudi Med J; 2003 Jan; 24(1):79-83. PubMed ID: 12590282
[TBL] [Abstract][Full Text] [Related]
37. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
38. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
[TBL] [Abstract][Full Text] [Related]
39. Antioxidative system parameters and level of IL-18 after surgery in patients with renal cell carcinoma according to gender.
Didziapetriene J; Kazbariene B; Surinenaite B; Krikstaponiene A; Ulys A; Uleckiene S; Samalavicius NE; Stukas R
Acta Physiol Hung; 2013 Mar; 100(1):107-14. PubMed ID: 23232703
[TBL] [Abstract][Full Text] [Related]
40. Superoxide dismutase activity in renal cell carcinoma.
Nakada T; Akiya T; Koike H; Katayama T
Eur Urol; 1988; 14(1):50-5. PubMed ID: 3342806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
